BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3432BiotechnologyAI medical concept stocks
$11.47 −$0.94 (-7.57%)
Pre-market · Oct 8, 9:10 am ET · After hours $11.31 -1.40%
Open$11.81
Prev close$12.41
Day range$10.81 – $11.95
Volume6.46M
Market cap$772.39M
P/E (TTM)–
Dividend yield–

DNA Stock News

Headlines matching Ginkgo Bioworks or the DNA ticker, most recent first.

  • BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $5Market news · 4 Sep 2026 · Direct mention
  • Kala Bio and Virotek Sign Letter of Intent With U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing ProductsGlobeNewswire · 24 Sep 2026 · Direct mention
  • TD Cowen Downgrades Ginkgo Bioworks(DNA.US) to Hold Rating, Cuts Target Price to $9 NegativeMarket news · 7 Aug 2026 · Direct mention
  • William Blair Initiates Ginkgo Bioworks(DNA.US) With Sell RatingMarket news · 6 Aug 2026 · Direct mention
  • Press Release: DNA X, Inc. Reports Second Quarter 2026 Financial ResultsDow Jones · 20 Aug 2026 · Direct mention
  • William Blair Maintains Ginkgo Bioworks(DNA.US) With Sell RatingMarket news · 14 Aug 2026 · Direct mention
  • Ginkgo Bioworks (DNA.US) will release its earnings report after market close on August 5.Market news · 31 Jul 2026 · Direct mention
  • TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $12Market news · 8 May 2026 · Direct mention
  • DNA X | 8-K: DNA X, Inc. Reports First Quarter 2026 Financial ResultsSEC · 21 May 2026 · Direct mention
  • Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)TipRanks · 11 May 2026 · Direct mention
  • BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $5 NegativeMarket news · 12 Mar 2026 · Direct mention
  • Sonim Technologies | 3: Initial statement of beneficial ownership of securities-10% Owner DNA Holdings Venture Inc.SEC · 21 Feb 2026 · Direct mention
  • TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Cuts Target Price to $12 NegativeMarket news · 8 Jan 2026 · Direct mention
  • BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Raises Target Price to $9 PositiveMarket news · 25 Aug 2025 · Direct mention
  • TR | OpenAI - 4o Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Raises Target Price to $12 PositiveMarket news · 12 Aug 2025 · Direct mention

Discussion

No comments yet — be the first to weigh in on DNA.

Leave a comment

Scroll to Top